Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration

被引：0
|
作者：
Alexander Egilman
Joshua D. Wallach
Jeremy Puthumana
Audrey D. Zhang
Jason L. Schwartz
Joseph S. Ross
机构：
[1] Yale-New Haven Hospital,Center for Outcomes Research and Evaluation
[2] Yale School of Public Health,Department of Environmental Health Sciences
[3] Yale School of Medicine,Department of Internal Medicine
[4] Duke University School of Medicine,Department of Medicine
[5] Yale School of Public Health,Department of Health Policy and Management
来源：
Journal of General Internal Medicine | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3281 / 3284
页数：3
相关论文
共 50 条
  • [1] Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration
    Egilman, Alexander
    Wallach, Joshua D.
    Puthumana, Jeremy
    Zhang, Audrey D.
    Schwartz, Jason L.
    Ross, Joseph S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (10) : 3281 - 3284
  • [2] Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
    Naci, Huseyin
    Smalley, Katelyn R.
    Kesselheim, Aaron S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (07): : 626 - 636
  • [3] Comparison of Duration of Postapproval vs Pivotal Trials for Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval, 2009-2018
    Wallach, Joshua D.
    Ramachandran, Reshma
    Bruckner, Till
    Ross, Joseph S.
    JAMA NETWORK OPEN, 2021, 4 (11) : E2133601
  • [4] Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval
    Wallach, Joshua D.
    Zhang, Audrey D.
    Skydel, Joshua J.
    Bartlett, Victoria L.
    Dhruva, Sanket S.
    Shah, Nilay D.
    Ross, Joseph S.
    JAMA NETWORK OPEN, 2021, 4 (11) : E2133667
  • [5] US Food and Drug Administration and Design of Drug Approval Studies
    Woloshin, Steven
    Schwartz, Lisa M.
    Frankel, Brittney
    Faerber, Adrienne
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (20): : 2163 - 2165
  • [6] Assessing the Safety and Effectiveness of Devices After US Food and Drug Administration Approval FDA-Mandated Postapproval Studies
    Reynolds, Ian S.
    Rising, Joshua P.
    Coukell, Allan J.
    Paulson, Kirsten H.
    Redberg, Rita F.
    JAMA INTERNAL MEDICINE, 2014, 174 (11) : 1773 - 1779
  • [7] Characteristics of Clinical Trials for the US Food and Drug Administration Accelerated Approval and Subsequent Confirmatory Trials: Implications for Drug Approval in Japan
    Mamiya, Hiroaki
    Narukawa, Mamoru
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (07) : 1345 - 1349
  • [8] Product Exclusivity Granted by the US Food and Drug Administration
    Novack, Gary D.
    OCULAR SURFACE, 2016, 14 (01): : 74 - 76
  • [9] Improving Food and Drug Administration-Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval
    Neumann, Peter J.
    Crummer, Elliott
    Chambers, James D.
    Tunis, Sean R.
    MILBANK QUARTERLY, 2023, 101 (04): : 1047 - 1075
  • [10] Accelerated Approval of Cancer Drugs-Righting the Ship of the US Food and Drug Administration
    DiMagno, Sarah S. P.
    Glickman, Aaron
    Emanuel, Ezekiel J.
    JAMA INTERNAL MEDICINE, 2019, 179 (07) : 922 - 923
12345